NCT03194646 2025-07-28
ASTEROID 6
Bayer
Phase 3 Terminated
Clinical Trials
10 trialsNCT03240523 2024-10-18
ASTEROID 5
Bayer
Phase 3 Terminated
NCT03400943 2023-05-03
Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 3)
Bayer
Phase 3 Terminated
NCT03476928 2022-07-08
ASTEROID 8
Bayer
Phase 3 Terminated
NCT03400956 2022-06-30
Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 4)
Bayer
Phase 3 Terminated
NCT03342859 2021-01-06
Mode of Action Study of Vilaprisan and Ulipristal Acetate in Patients With Uterine Fibroids for Whom Surgery is Planned
Bayer
Phase 1 Terminated
NCT03699176 2020-01-18
ASTEROID 7
Bayer
Phase 3 Withdrawn
NCT03411980 2019-12-03
Pharmacokinetics and Safety of Vilaprisan in Renal Impairment
Bayer
Phase 1 Completed
NCT02131662 2017-12-08
ASTEROID 1
Bayer
Phase 2 Completed
NCT03092999 2017-08-18
Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1002670 (Vilaprisan)
Bayer
Phase 1 Completed